Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Painreform Ltd (NQ: PRFX )

0.6826 -0.0175 (-2.50%)
Streaming Delayed Price Updated: 3:50 PM EDT, Jun 5, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 33,792
Open 0.7254
Bid (Size) 0.6969 (6)
Ask (Size) 0.7500 (89)
Prev. Close 0.7001
Today's Range 0.6500 - 0.7497
52wk Range 0.6500 - 26.41
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
PRFX Stock Earnings: PainReform Misses EPS for Q1 2024
PRFX stock results show that PainReform missed analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Skillsoft Corp. (NASDAQ: SKIL) fell sharply during Tuesday’s session after the company reported mixed fourth-quarter financial results and issued FY25 revenue guidance below estimates. 
Via Benzinga

Performance

YTD
-73.54%
-73.54%
1 Month
-18.74%
-18.74%
3 Month
-66.54%
-66.54%
6 Month
-75.00%
-75.00%
1 Year
-86.35%
-86.35%

More News

Read More
Why Ascent Solar Technologies Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
PainReform Ltd. (NASDAQ: PRFX) Near the Top of Equities by Percentage Gain on 7/20
Via Investor Brand Network
Why PriceSmart Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
EXCLUSIVE: PainReform's Non-Opiate Post-Surgical Pain Relief Treatment Outperforms Rival Medicine Under Various Testing Conditions
Via Benzinga
EXCLUSIVE: PainReform Reaches 50% Enrollment Target For Phase 3 Study For Its Lead Postoperative Pain Drug
Via Benzinga
Why Bluegreen Vacations Shares Are Trading Higher By Around 105%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
7 Stocks Under $10 to Buy for August
Via InvestorPlace
EXCLUSIVE: Top 10 Most-Searched Tickers On Benzinga Pro In July - See Where Tesla, Carvana, Rivian, Nikola And More Rank
Via Benzinga
Dow On Track For 9 Straight After Johnson & Johnson Earnings
Via Talk Markets
Nasdaq Down 50 Points; Tesla Earnings Beat Expectations
Via Benzinga
Why Infosys Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Why Is Discover Financial (DFS) Stock Down 13% Today?
Via InvestorPlace
Why Is Netcapital (NCPL) Stock Down 42% Today?
Via InvestorPlace
Why Is Eliem Therapeutics (ELYM) Stock Up 6% Today?
Via InvestorPlace
Why Nanobiotix Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why Is PainReform (PRFX) Stock Up 38% Today?
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
Why Acumen Pharmaceuticals Shares Are Trading Higher By Over 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Why BYND Cannasoft Enterprises Shares Are Trading Lower By 40%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
PRFX Stock: The $2.7 Million Reason PainReform Is Up 100% Today
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.